Labhardt, Niklaus D <br/><br/>
Is zidovudine first-line therapy virologically comparable to tenofovir in resource-limited settings?  [electronic resource] 

 -  Tropical medicine & international health : TM & IH  Jul 2015 
 - 914-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-3156 
<br/><br/><label>Standard No.: </label>10.1111/tmi.12509  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Adult<br/>Alkynes<br/>Anti-HIV Agents--pharmacology<br/>Antiretroviral Therapy, Highly Active<br/>Benzoxazines--therapeutic use<br/>Cross-Sectional Studies<br/>Cyclopropanes<br/>Female<br/>HIV--drug effects<br/>HIV Infections--drug therapy<br/>Health Resources<br/>Humans<br/>Lamivudine--therapeutic use<br/>Lesotho<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Organophosphonates--pharmacology<br/>Tenofovir<br/>Viral Load<br/>Zidovudine--pharmacology